Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Manitoba
With
Manitoba Medical Service Foundation
Age
50–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
men aged 50 years or older
diagnosed with adenocarcinoma prostate cancer
will initiate and receive continuous ADT (luteinizing hormone releasing hormone agonist (LHRH) or combination of LHRH and anti-androgen) for at least 12 months after recruitment
Patients will also consent to participating in the study.
You may not be if
severe cardiac disease (New York Heart Association class III or greater)
uncontrolled sinus tachycardia (\> 120 beats per minute)
uncontrolled congestive heart failure third-degree atrio-ventricular heart block, active pericarditis or myocarditis, recent embolism, thrombophlebitis, deep vein thrombosis, resting ST displacement (\> 3mm), uncontrolled diabetes, uncontrolled pain, cognitive impairment, history of falls due to balance impairment or lost of consciousness, severe neuromusculoskeletal conditions that limit their ability to perform walking exercise (including ataxia, peripheral or sensory neuropathy, unstable bone lesion, severe arthritis, pathological lower limb fractures within 6 months, lower limb amputation).
Clareo Health | Exercise in Men With Prostate Cancer
